Chronic HBV-related liver disease

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 72-84

  Rizzetto, Mario ^a   Ciancio, Alessia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic hepatitis B; Chronic liver disease; Clinical manifestation and diagnosis of HBV; Epidemiology of HBV; Hepatitis B virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DNA DETERMINATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOPROPHYLAXIS; INCIDENCE; INFECTION PREVENTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; POLYARTERITIS NODOSA; POLYNEUROPATHY; PORTAL HYPERTENSION; PREVALENCE; REVIEW; SEXUAL BEHAVIOR; SYSTEMIC VASCULITIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER DISEASES; MODELS, BIOLOGICAL;

HEPATITIS B VIRUS;

EID: 39849100002     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.013     Document Type: Review

References (69)

1. Alter M.J., and Margolis H.S. The emergence of hepatitis B as a sexually transmitted disease. Med. Clin. North Am. 74 (1990) 1529-1541
2. Alter M.J., Holland P.V., Morrow A.G., Purcell R.H., Feinstone S.M., and Moritsugu Y. Clinical and serological analysis of transfusion-associated hepatitis. Lancet 2 (1975) 838-841
3. Alter M.J., Purcell R.H., Gerin J.L., London W.T., Kaplan P.M., McAuliffe V.J., Wagner J., and Holland P.V. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect. Immun. 16 (1977) 928-933
4. Andre E. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18 (2000) S20-S22
5. Beasley R.P., and Hwang L.-Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J. Infect. Dis. 147 (1983) 185-190
6. Benvegnu L., Gios M., Boccato S., and Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53 (2004) 744-749
7. Blumberg B.S., Alter H.J., and Visnich S. A new antigen in leukemia sera. JAMA 191 (1965) 541-546
8. Bortolotti F., Jara P., Crivellaro C., Hierro L., Cadrobbi P., Frauca E., Camarena C., De La Vega A., Diaz C., De Moliner L., and Noventa F. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J. Hepatol. 29 (1998) 184-190
9. Bottcher B., Wynne S.A., and Crowther R.A. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386 (1997) 88-91
10. Brunetto M.R., Oliveri F., Coco B., Leandro G., Colombatto P., Gorin J.M., and Bonino F. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long-term cohort study. J. Hepatol. 36 (2002) 263-270
11. Brunetto M.R., Stemler M., Schodel F., Will H., Ottobrelli A., Rizzetto M., Verme G., and Bonino F. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital. J. Gastroenterol. 21 (1989) 151-154
12. Centers for Disease Control (CDC), 1978. Lack of transmission of hepatitis B to humans after oral exposure to hepatitis B surface antigen-positive saliva. MMWR Morb. Mortal Wkly. Rep. 27. pp. 247-248.
13. Centers for Disease Control and Prevention (CDC). 1995. Update: recommendations to prevent hepatitis B virus transmission in United States. MMWR Morb. Mortal Wkly. Rep. 44. pp. 574-575.
14. Centers for Disease Control and Prevention (CDC), 2007. Progress in hepatitis B prevention through universal infant vaccination - China 1997-2006. MMWR Morb. Mortal Wkly. Rep. 56. pp. 441-445.
15. Chan H.L., Leung N.W., Lau T.C., Wong M.L., and Sung J.J. Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy. J. Clin. Microbiol. 38 (2000) 32053208
16. Chang M.H., Hsu H.Y., Hsu H.C., Ni Y.H., Chen J.S., and Chen D.S. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 22 (1995) 1387-1392
17. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., Liang D.C., Shau W.Y., and Chen D.S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N. Engl. J. Med. 336 (1997) 1855-1859
18. Chu C.J., Hussain M., and Lok A.S. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122 (2002) 1756-1762
19. Crowther R., Kiselev N., Bottcher B., Berriman J., Borisova G., Ose V., and Pumpens P. Three dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77 (1994) 943-950
20. Da Villa G., Sepe A., Piccinino F., and Scolastico C. Pilot project of universal hepatitis B vaccination of newborns in a hyperendemic area: results after 17 years. In: Margolis H.S., Alter M.J., Liang T.J., and Dienstag J.L. (Eds). Viral Hepatitis and Liver Disease (2002), International Medical Press, Atlanta, USA
21. Decker R.H. Diagnosis of acute and chronic hepatitis B. In: Zuckerman A.J., and Thomas H.C. (Eds). Viral Hepatitis (1998), Churchill, Livingstone
22. Donato F., Tagger A., Gelatti U., Parrinello G., Boffetta P., Albertini A., Decarli A., Trevisi P., Ribero M.L., Martelli C., Porru S., and Nardi G. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am. J. Epidemiol. 155 (2002) 323-331
23. Donato F., Gelatti U., Limina R.M., and Fattovich G. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 25 (2006) 3756-3770
24. Fattovich G. Natural history and prognosis of hepatitis B. Semin. Liver Dis. 23 (2003) 47-58
25. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
26. Fung S.K., and Lok A.S. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?. Hepatology 40 (2004) 790-792
27. Funk M.L., Rosenberg D.M., and Lok A.S. World-wide epidemiology of HBeAg negative chronic hepatitis Band associated precore and core promoter variants. J. Viral Hepatol. 9 (2002) 52-61
28. Goldstein S.T., Alter M.J., Williams I.T., Moyer L.A., Judson F.N., Mottram K., Fleenor M., Ryder P.L., and Margolis H.S. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J. Infect. Dis. 185 (2002) 713-719
29. Healy C.M., Cafferkey M.T., Butler K.M., Cahill I., McMorrow J., Philbin M., Beckett M., Mackey R., MacMathuna P., Dooley S., Hall W.W., and McKenna P. Antenatal hepatitis B screening - is there a need for a national policy?. Irish Med. J. 94 (2001) 111-112
30. Hsu Y.S., Chien R.N., Yeh C.T., Sheen I.S., Chiou H.Y., Chu C.M., and Liaw Y.F. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35 (2002) 1522-1527
31. Hutin Y.J., Goldstein S.T., Varma J.K., O'Dair J.B., Mast E.E., Shapiro C.N., and Alter M.J. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect. Control Hosp. Epidemiol. 20 (1999) 731-735
32. Hyams K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin. Infect. Dis. 20 (1995) 992-1000
33. Kao J.H., and Chen D.S. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2 (2002) 395-403
34. Kao J.H., Chen P.J., Lai M.Y., and Chen D.S. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124 (2003) 327-334
35. Kao J.H., Chen P.J., Lai M.Y., and Chen D.S. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J. Med. Virol. 72 (2004) 363-369
36. Kent G.P., Brondum J., Keenlyside R.A., LaFazia L.M., and Scott H.D. A large outbreak of acupuncture-associated hepatitis B. Am. J. Epidemiol. 127 (1988) 591-598
37. Kuroki K., Eng F., Ishikawa T., Harada F., and Ganem D. gp180, a host cell glycoprotein that binds duck hepatitis B virus particles, is encoded by a novel member of the carboxypeptidase gene family. J. Biol. Chem. 270 (1995) 15022-15028
38. Laskus T., Rakela J., Nowicki M.J., and Persing D.H. Hepatitis B core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 109 (1995) 1618-1623
39. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden and vaccine prevention. J. Clin. Virol. 34 (2005) S1-S3
40. Liaw Y.F. Hepatitis flares and hepatitis B antigen seroconversion: implication in anti-hepatitis B virus therapy. J. Gastroenterol. Hepatol. 18 (2003) 246-252
41. Limentani, A.E., Elliott, L.M., Noah, N.D.,1 Lamborn, J.K., 1979. An outbreak of hepatitis B from tattooing. Lancet 2, pp. 86-88.
42. Locarnini S. Molecular virology of hepatitis B virus. Semin. Liver Dis. 24 (2004) 3-10
43. Loeb K., Jerome K., Goddard J., Huang M., Cent A., and Corey L. High throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32 (2000) 626-629
44. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 34 (2001) 1225-1241
45. Lok A.S.F., Akarca U., and Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc. Natl. Acad. Sci. USA 91 (1994) 4077-4081
46. Lurman A. Eine icterus epidemic. Wochenschrift 22 (1885) 20
47. Marion P.L., Oshiro L., Regnery D.C., Scullard G.H., and Robinson W.S. A virus in Beechey ground squirrels that is related to hepatitis B virus of man. Proc. Natl. Acad. Sci. USA 77 (1980) 2941-2945
48. Mast E.E., and Alter M.J. Prevention of hepatitis B virus infection among health care workers. In: Ellis R.S. (Ed). Hepatitis B Vaccines in Clinical Practice (1992), Marcel Dekker, New York
49. McMahon B.J., Heyward W.L., Templin D.W., Clement D., and Lanier A.P. Hepatitis B-associated polyarteritis nodosa in alaskan eskimos: clinical and epidemiological features and long-term follow up. Hepatology 9 (1989) 97-101
50. McMahon B.J., Holck P., Bulkow I., and Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann. Int. Med. 135 (2001) 759-768
51. Noborg D., Gusdal A., Pisa E.K., Hedrum A., and Lindh M. Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test. J. Clin. Microbiol. 37 (1999) 2793-2797
52. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa M., and Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen negative phenotype in carriers with antibody to e antigen. J. Virol. 68 (1994) 8102-8110
53. Pawlotsky J.M. Molecular diagnosis of viral hepatitis. Gastroenterology 122 (2002) 1554-1568
54. Perrillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunomediated liver disease. Gastroenterology 120 (2001) 1009-1022
55. Plitt S.S., Somily A.M., and Singh A.E. Outcome from a Canadian public health prenatal screening program for hepatitis B: 1997-2004. Can. J. Pub. Health 98 (2007) 194-197
56. Pruss-Ustun A., Rapiti E., and Hutin Y. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am. J. Ind. Med. 48 (2005) 482-490
57. Quale J.M., Landman D., Wallace B., Atwood E., Ditore V., and Fruchter G. Deja vu: nosocomial hepatitis B virus transmission and fingerstick monitoring. Am. J. Med. 105 (1998) 296-301
58. Raimondo G., Pollicino T., and Squadrito G. What is the clinical impact of occult hepatitis B virus infection. Lancet 365 (2005) 630-640
59. Rosenheim M., Cadral J.F., Stuyver L., Dorent R., Golliot F., Astagneau P., Di Martino V., Delcourt A., Gandjbakhch I., Huraux J.M., and Lunel F. Nosocomial transmission of hepatitis B virus associated with endomyocardial biopsy. Gastroenterol. Clin. Biol. 30 (2006) 1274-1280
60. Seeff L.B., Beebe G.W., Hoofnagle J.H., Norman J.E., Buskell-Bales Z., Waggoner J.G., Kaplowitz N., Koff R.S., Petrini Jr. J.L., Schiff E.R., et al. A serological follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N. Engl. J. Med. 316 (1987) 965-970
61. Summers J., and Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29 (1982) 403-415
62. Summers J., Smolec J.M., and Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75 (1978) 4533-4537
63. Tarantola A., Abiteboul D., and Rachline A. Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases. Am. J. Infect. Control 34 (2006) 367-375
64. Tassopoulos N.C., Papaevangelou G.J., Sjogren M.H., Roumeliotou-Karayannis A., Gerin J.L., and Purcell R.H. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 92 (1987) 1844-1850
65. Urban S., Schwarz C., Marx U.C., Zentgraf H., Schaller H., and Multhaup G. Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction. EMBO J. 19 (2000) 1217-1227
66. Yu M.W., Yeh S.H., Chen P.J., Liaw Y.F., Lin C.L., Liu C.J., Shih W.L., Kao J.H., Chen D.S., and Chen C.J. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J. Natl.Cancer Inst. 97 (2005) 265-272
67. Yuan J.M., Govindarajan S., Arakawa K., and Yu M.C. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US. Cancer 101 (2004) 1009-1017
68. Zanetti A., Tanzi E., Manzillo G., Maio G., Sbreglia C., Caporaso N., Thomas H., and Zuckerman A.J. Hepatitis B variants in Europe. Lancet 2 (1988) 1132-1133
69. Zuckerman J.N. Review: hepatitis B immune globulin for prevention of hepatitis B infection. J. Med. Virol. 79 (2007) 919-921